Luzar B, Calonje E, Lazar AJ.

Fibrohistiocytic tumors.

In: Diagnostic Atlas of Cutaneous Mesenchymal Neoplasia. USA: Elsevier; 2019, p. 183- 236.

 

Povezano:



 

Luzar B, Calonje E, Lazar AJ.

Fibroblasti and myofibroblasti tumors.

In: Diagnostic Atlas of Cutaneous Mesenchymal Neoplasia. USA: Elsevier; 2019, p. 51-182.

 

Povezano:



 

Lazar AJ, Calonje E, Luzar B.

Adipocytic tumors.

In: Diagnostic Atlas of Cutaneous Mesenchymal Neoplasia. USA: Elsevier; 2019, p. 1-50.

 

Povezano:



 

Calonje E, Lazar AJ, Luzar B (editors).

Diagnostic Atlas of Cutaneous Mesenchymal Neoplasia.

USA: Elsevier; 2019.

 

Povezano:



 

Prikaz primera


Marovt M, Luzar B, Marko PB.

Acrally emphasized papules-a case report.

Hautarzt 2019; 70: 44-46.

 

Povezano:



0.7

faktor vpliva

Raziskovalni


Bizjak Ogrinc U, Senčar S, Luzar B, Lukanović A.

Efficacy of Non-ablative Laser Therapy for Lichen Sclerosus: A Randomized Controlled Trial.

J Obstet Gynaecol Can. 2019; 41: 1717-1725.

 

Povezano:



0.7

faktor vpliva

Raziskovalni


Kastnerova L, Luzar B, Goto K, Grishakov V, Gatalica Z, Kamarachev J, Martinek P, Hájková V, Grossmann P, Imai H, Fukui H, Michal M, Kazakov DV.

Secretory Carcinoma of the Skin: Report of 6 Cases, Including a Case With a Novel NFIX-PKN1 Translocation.

Am J Surg Pathol. 2019; 43: 1092-1098.

 

Povezano:



6.1

faktor vpliva

Raziskovalni


Rashid M, van der Horst M, Mentzel T, Butera F, Ferreira I, Pance A, Rütten A, Luzar B, Marusic Z, de Saint Aubain N, Ko JS, Billings SD, Chen S, Abi Daoud M, Hewinson J, Louzada S, Harms PW, Cerretelli G, Robles-Espinoza CD, Patel RM, van der Weyden L, Bakal C, Hornick JL, Arends MJ, Brenn T, Adams DJ.

ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.

Nat Commun 2019; 10: 2213-.

 

Povezano:



11.8

faktor vpliva

Prikaz primera


Chung IA, Petelin K, Pižem J, Luzar B.

Cutaneous aneurysmal bone cyst-First report of a case and literature review.

J Cutan Pathol 2019; 46: 858-863.

 

Povezano:



1.5

faktor vpliva